{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:03:07Z","timestamp":1774677787788,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye and Vis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ocular surface disease in glaucoma patients is a significant ocular co-morbidity that can affect 40% to 59% of these patients worldwide.\u00a0The current study was aimed at evaluating the potential clinical benefit of an intense pulsed light (IPL)-based treatment in glaucomatous patients with ocular surface disease due to prolonged hypotensive eyedrop treatments. To our knowledge, this is the first series analyzing the therapeutic effect of this treatment option in this type of patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This non-comparative prospective case series study enrolled a total of 30 glaucoma patients ranging in age from 57 to 94\u00a0years old and treated with hypotensive eyedrops for years with dry eye symptomatology. All patients received four sessions of IPL treatment using the Optima IPL system (Lumenis, Yokneam, Israel) adjusted to the official optimized Lumenis setting. Changes in symptomatology, corneal staining, conjunctival hyperemia, non-invasive break-up time (NIBUT), tear osmolarity, tear meniscus height (TMH), meiboscore and meibomian gland expressibility was analyzed after treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Statistically significant reductions were observed after IPL treatment in the symptomatology scores measured with different questionnaires\u00a0[ocular surface disease index (OSDI), standard patient evaluation of eye dryness (SPEED) and symptom assessment questionnaire in dry eye (SANDE)] as well as with the visual analogue scale (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Mean change in OSDI was\u2009\u2212\u200915.0\u2009\u00b1\u200911.3. A significant reduction was found after treatment in the corneal staining score (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). A significant reduction was found in tear film meniscus height (<jats:italic>P<\/jats:italic>\u2009=\u20090.012), as well as in tear film osmolarity (<jats:italic>P<\/jats:italic>\u2009=\u20090.001). A significant reduction was also found in meibomian gland expressibility (<jats:italic>P<\/jats:italic>\u2009=\u20090.003), changing the percentage of grade 3 eyes from 44.4% before IPL to 17.2% after treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>IPL therapy combined with meibomian gland expression (MGX) seems to be an effective option to improve symptomatology in glaucomatous patients with ocular surface disease due to prolonged hypotensive eyedrop treatments, with an additional improvement in clinical signs, such as tear osmolarity and corneal staining.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40662-022-00284-4","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:25:55Z","timestamp":1648779955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Intense pulsed light-based treatment for the improvement of symptoms in glaucoma patients treated with hypotensive eye drops"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9441-0542","authenticated-orcid":false,"given":"Jose Maria","family":"Martinez-de-la-Casa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Oribio-Quinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almudena","family":"Milans-del-Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Perez-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Morales-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Garcia-Bella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Manuel","family":"Benitez-del-Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Garcia-Feijoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Pi\u00f1ero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"issue":"1","key":"284_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/ICL.0000000000000544","volume":"45","author":"X Zhang","year":"2019","unstructured":"Zhang X, Vadoothker S, Munir WM, Saeedi O. Ocular surface disease and glaucoma medications: a clinical approach. Eye Contact Lens. 2019;45(1):11\u20138.","journal-title":"Eye Contact Lens"},{"key":"284_CR2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00417-012-1943-6","volume":"250","author":"R Arita","year":"2012","unstructured":"Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Tomidokoro A, et al. Effects of long-term topical anti-glaucoma medications on meibomian glands. Graefes Arch Clin Exp Ophthalmol. 2012;250:1181\u20135.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"284_CR3","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/ICO.0b013e31823f8e7d","volume":"31","author":"R Arita","year":"2012","unstructured":"Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Tomidokoro A, et al. Comparison of the long-term effects of various topical antiglaucoma medications on meibomian glands. Cornea. 2012;31(11):1229\u201334.","journal-title":"Cornea"},{"issue":"3","key":"284_CR4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1167\/iovs.15-17455","volume":"57","author":"E Villani","year":"2016","unstructured":"Villani E, Sacchi M, Magnani F, Nicodemo A, Williams SE, Rossi A, et al. The ocular surface in medically controlled glaucoma: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2016;57(3):1003\u201310.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"284_CR5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/IJG.0000000000001168","volume":"28","author":"D Tiedemann","year":"2019","unstructured":"Tiedemann D, Mouhammad ZA, Utheim TP, Dartt DA, Heegaard S, Petrovski G, et al. Conjunctival goblet cells, the overlooked cells in glaucoma treatment. J Glaucoma. 2019;28(4):325\u201333.","journal-title":"J Glaucoma"},{"issue":"8","key":"284_CR6","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.4103\/ijo.IJO_2100_18","volume":"67","author":"SM Lee","year":"2019","unstructured":"Lee SM, Lee JE, Kim SI, Jung JH, Shin J. Effect of topical glaucoma medication on tear lipid layer thickness in patients with unilateral glaucoma. Indian J Ophthalmol. 2019;67(8):1297\u2013302.","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"284_CR7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10792-019-01236-z","volume":"40","author":"A Guarnieri","year":"2020","unstructured":"Guarnieri A, Carnero E, Bleau AM, Alfonso-Bartolozzi B, Moreno-Monta\u00f1\u00e9s J. Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients. Int Ophthalmol. 2020;40(3):741\u201351.","journal-title":"Int Ophthalmol"},{"issue":"3","key":"284_CR8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.clae.2015.02.001","volume":"38","author":"A Camp","year":"2015","unstructured":"Camp A, Wellik SR, Tzu JH, Feuer W, Arheart KL, Sastry A, et al. Dry eye specific quality of life in veterans using glaucoma drops. Cont Lens Anterior Eye. 2015;38(3):220\u20135.","journal-title":"Cont Lens Anterior Eye"},{"issue":"5","key":"284_CR9","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s12325-018-0699-8","volume":"35","author":"G Roberti","year":"2018","unstructured":"Roberti G, Agnifili L, Berardo F, Riva I, Figus M, Manni G, et al. Prospective, randomized, single masked, parallel study exploring the effects of a preservative-free ophthalmic solution containing hyaluronic acid 0.4% and taurine 0.5% on the ocular surface of glaucoma patients under multiple long-term topical hypotensive therapy. Adv Therapy. 2018;35(5):686\u201396.","journal-title":"Adv Therapy."},{"issue":"6","key":"284_CR10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/IJG.0000000000000316","volume":"25","author":"X Cui","year":"2016","unstructured":"Cui X, Xiang J, Zhu W, Wei A, Le Q, Xu J, et al. Vitamin A palmitate and carbomer gel protects the conjunctiva of patients with long-term prostaglandin analogs application. J Glaucoma. 2016;25(6):487\u201392.","journal-title":"J Glaucoma"},{"issue":"9","key":"284_CR11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1089\/jop.2016.0117","volume":"33","author":"A Di Zazzo","year":"2017","unstructured":"Di Zazzo A, Roberti G, Mashaghi A, Abud TB, Pavese D, Bonini S. Use of topical cannabinomimetic palmitoylethanolamide in ocular surface disease associated with antiglaucoma medications. J Ocul Pharmacol Ther. 2017;33(9):670\u20137.","journal-title":"J Ocul Pharmacol Ther"},{"key":"284_CR12","first-page":"711","volume":"8","author":"C Galbis-Estrada","year":"2013","unstructured":"Galbis-Estrada C, Pinazo-Dur\u00e1n MD, Cant\u00fa-Dibildox J, Marco-Ram\u00edrez C, D\u00edaz-Ll\u00f3pis M, Ben\u00edtez-del-Castillo J. Patients undergoing long-term treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acids. Clin Interv Aging. 2013;8:711\u20139.","journal-title":"Clin Interv Aging"},{"issue":"9","key":"284_CR13","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ophtha.2020.03.009","volume":"127","author":"EJ Wladis","year":"2020","unstructured":"Wladis EJ, Aakalu VK, Foster JA, Freitag SK, Sobel RK, Tao JP, et al. Intense pulsed light for meibomian gland disease: a report by the American Academy of Ophthalmology. Ophthalmology. 2020;127(9):1227\u201333.","journal-title":"Ophthalmology"},{"issue":"3","key":"284_CR14","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1167\/iovs.14-15764","volume":"56","author":"JP Craig","year":"2015","unstructured":"Craig JP, Chen YH, Turnbull PR. Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2015;56(3):1965\u201370.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"284_CR15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcjo.2016.01.005","volume":"51","author":"PK Gupta","year":"2016","unstructured":"Gupta PK, Vora GK, Matossian C, Kim M, Stinnett S. Outcomes of intense pulsed light therapy for treatment of evaporative dry eye disease. Can J Ophthalmol. 2016;51(4):249\u201353.","journal-title":"Can J Ophthalmol"},{"key":"284_CR16","doi-asserted-by":"publisher","DOI":"10.3791\/57811","author":"L Vigo","year":"2019","unstructured":"Vigo L, Giannaccare G, Sebastiani S, Pellegrini M, Carones F. Intense pulsed light for the treatment of dry eye owing to meibomian gland dysfunction. J Vis Exp. 2019. https:\/\/doi.org\/10.3791\/57811.","journal-title":"J Vis Exp"},{"issue":"5","key":"284_CR17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s10792-019-01278-3","volume":"40","author":"S Yurttaser Ocak","year":"2020","unstructured":"Yurttaser Ocak S, Karakus S, Ocak OB, Cakir A, Bolukbasi S, Erden B, et al. Intense pulse light therapy treatment for refractory dry eye disease due to meibomian gland dysfunction. Int Ophthalmol. 2020;40(5):1135\u201341.","journal-title":"Int Ophthalmol"},{"issue":"4","key":"284_CR18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/photob.2019.4689","volume":"38","author":"D Li","year":"2020","unstructured":"Li D, Lin SB, Zhang MZ, Cheng B. Preliminary assessment of intense pulsed light treatment on the upper eyelids for meibomian gland dysfunction. Photobiomodul Photomed Laser Surg. 2020;38(4):249\u201354.","journal-title":"Photobiomodul Photomed Laser Surg"},{"issue":"2","key":"284_CR19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.optom.2020.08.009","volume":"14","author":"C Verg\u00e9s","year":"2021","unstructured":"Verg\u00e9s C, Salgado-Borges J, Ribot FM. Prospective evaluation of a new intense pulsed light, thermaeye plus, in the treatment of dry eye disease due to meibomian gland dysfunction. J Optom. 2021;14(2):103\u201313.","journal-title":"J Optom"},{"issue":"3","key":"284_CR20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/photob.2020.4913","volume":"39","author":"S Zhang-Nunes","year":"2021","unstructured":"Zhang-Nunes S, Guo S, Lee D, Chang J, Nguyen A. Safety and efficacy of an augmented intense pulsed light protocol for dry eye syndrome and blepharitis. Photobiomodul Photomed Laser Surg. 2021;39(3):178\u201384.","journal-title":"Photobiomodul Photomed Laser Surg"},{"issue":"2","key":"284_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jfo.2020.04.061","volume":"44","author":"S Egri","year":"2021","unstructured":"Egri S, Van Hollebecke I, Guindolet D, Manenti C, Rougier H, Gabison E, et al. Efficacy of intense pulsed light therapy in the treatment of meibomian gland dysfunction-related severe dry eye. J Fr Ophthalmol. 2021;44(2):169\u201375.","journal-title":"J Fr Ophthalmol"},{"key":"284_CR22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2147\/OPTH.S130706","volume":"11","author":"SJ Dell","year":"2017","unstructured":"Dell SJ, Gaster RN, Barbarino SC, Cunningham DN. Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction. Clin Ophthalmol. 2017;11:817\u201327.","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"284_CR23","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1089\/pho.2017.4402","volume":"36","author":"B Rong","year":"2018","unstructured":"Rong B, Tang Y, Tu P, Liu R, Qiao J, Song W, et al. Intense pulsed light applied directly on eyelids combined with meibomian gland expression to treat meibomian gland dysfunction. Photomed Laser Surg. 2018;36(6):326\u201332.","journal-title":"Photomed Laser Surg"},{"issue":"1","key":"284_CR24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jtos.2018.11.004","volume":"17","author":"R Arita","year":"2019","unstructured":"Arita R, Fukuoka S, Morishige N. Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Ocul Surf. 2019;17(1):104\u201310.","journal-title":"Ocul Surf"},{"issue":"9","key":"284_CR25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/photob.2018.4599","volume":"37","author":"R Toyos","year":"2019","unstructured":"Toyos R, Toyos M, Willcox J, Mulliniks H, Hoover J. Evaluation of the safety and efficacy of intense pulsed light treatment with meibomian gland expression of the upper eyelids for dry eye disease. Photobiomodul Photomed Laser Surg. 2019;37(9):527\u201331.","journal-title":"Photobiomodul Photomed Laser Surg"},{"issue":"8","key":"284_CR26","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1080\/02713683.2020.1867750","volume":"46","author":"Y Chen","year":"2021","unstructured":"Chen Y, Li J, Wu Y, Lin X, Deng X, Yun-E Z. Comparative evaluation in intense pulsed light therapy combined with or without meibomian gland expression for the treatment of meibomian gland dysfunction. Curr Eye Res. 2021;46(8):1125\u201331.","journal-title":"Curr Eye Res"},{"issue":"1","key":"284_CR27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/ICL.0000000000000711","volume":"47","author":"X Yan","year":"2021","unstructured":"Yan X, Hong J, Jin X, Chen W, Rong B, Feng Y, et al. The efficacy of intense pulsed light combined with meibomian gland expression for the treatment of dry eye disease due to meibomian gland dysfunction: a multicenter, randomized controlled trial. Eye Contact Lens. 2021;47(1):45\u201353.","journal-title":"Eye Contact Lens"},{"issue":"4","key":"284_CR28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jtos.2020.06.002","volume":"18","author":"B Tashbayev","year":"2020","unstructured":"Tashbayev B, Yazdani M, Arita R, Fineide F, Utheim TP. Intense pulsed light treatment in meibomian gland dysfunctions: a concise review. Ocul Surf. 2020;18(4):583\u201394.","journal-title":"Ocul Surf"},{"issue":"4","key":"284_CR29","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/ICO.0b013e318239aaea","volume":"31","author":"SS Lane","year":"2012","unstructured":"Lane SS, DuBiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR, et al. A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea. 2012;31(4):396\u2013404.","journal-title":"Cornea"},{"issue":"5","key":"284_CR30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ophtha.2007.06.031","volume":"115","author":"R Arita","year":"2008","unstructured":"Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology. 2008;115(5):911\u20135.","journal-title":"Ophthalmology"},{"key":"284_CR31","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archderm.1988.01670060015008","volume":"124","author":"TB Fitzpatrick","year":"1998","unstructured":"Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dematol. 1998;124:869\u201371.","journal-title":"Arch Dematol"},{"issue":"6","key":"284_CR32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/APO.0000000000000327","volume":"9","author":"LM Nijm","year":"2020","unstructured":"Nijm LM, De Benito-Llopis L, Rossi GC, Vajaranant TS, Coroneo MT. Understanding the dual dilemma of dry eye and glaucoma: an international review. Asia Pac J Ophthalmol (Phila). 2020;9(6):481\u201390.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"7","key":"284_CR33","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s10792-020-01337-0","volume":"40","author":"Y Wu","year":"2020","unstructured":"Wu Y, Li J, Hu M, Zhao Y, Lin X, Chen Y, et al. Comparison of two intense pulsed light patterns for treating patients with meibomian gland dysfunction. Int Ophthalmol. 2020;40(7):1695\u2013705.","journal-title":"Int Ophthalmol"},{"issue":"7","key":"284_CR34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1089\/photob.2019.4788","volume":"38","author":"Q Fan","year":"2020","unstructured":"Fan Q, Pazo EE, You Y, Zhang C, Zhang C, Xu L, et al. Subjective quality of vision in evaporative dry eye patients after intense pulsed light. Photobiomodul Photomed Laser Surg. 2020;38(7):444\u201351.","journal-title":"Photobiomodul Photomed Laser Surg"},{"issue":"3","key":"284_CR35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1089\/photob.2020.4826","volume":"39","author":"D Li","year":"2021","unstructured":"Li D, Lin SB, Cheng LH, Zhang MZ, Cheng B. Intense pulsed light treatment for itch associated with allergic keratoconjunctivitis: a retrospective study of 35 cases. Photobiomodul Photomed Laser Surg. 2021;39(3):196\u2013203.","journal-title":"Photobiomodul Photomed Laser Surg"},{"key":"284_CR36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/OPTH.S229815","volume":"14","author":"AL Mylla Boso","year":"2020","unstructured":"Mylla Boso AL, Gasperi E, Fernandes L, Costa VP, Alves M. Impact of ocular surface disease treatment in patients with glaucoma. Clin Ophthalmol. 2020;14:103\u201311.","journal-title":"Clin Ophthalmol"},{"key":"284_CR37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2147\/OPTH.S96433","volume":"10","author":"J Tellez-Vazquez","year":"2016","unstructured":"Tellez-Vazquez J. Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: results of a prospective multicenter study. Clin Ophthalmol. 2016;10:617\u201326.","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"284_CR38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10384-016-0430-8","volume":"60","author":"SW Jin","year":"2016","unstructured":"Jin SW, Min JS. Clinical evaluation of the effect of diquafosol ophthalmic solution in glaucoma patients with dry eye syndrome. Jpn J Ophthalmol. 2016;60(3):150\u20135.","journal-title":"Jpn J Ophthalmol"},{"key":"284_CR39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ajo.2017.08.021","volume":"183","author":"R Liu","year":"2017","unstructured":"Liu R, Rong B, Tu P, Tang Y, Song W, Toyos R, et al. Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating meibomian gland dysfunction. Am J Ophthalmol. 2017;183:81\u201390.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"284_CR40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.oftal.2019.03.009","volume":"94","author":"LF Mej\u00eda","year":"2019","unstructured":"Mej\u00eda LF, Gil JC, Jaramillo M. Intense pulsed light therapy: a promising complementary treatment for dry eye disease. Arch Soc Esp Oftalmol (Engl Ed). 2019;94(7):331\u20136.","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"issue":"5","key":"284_CR41","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/ICO.0b013e3182714425","volume":"32","author":"J Hong","year":"2013","unstructured":"Hong J, Sun X, Wei A, Cui X, Li Y, Qian T, et al. Assessment of tear film stability in dry eye with a newly developed keratograph. Cornea. 2013;32(5):716\u201321.","journal-title":"Cornea"},{"issue":"11","key":"284_CR42","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.18240\/ijo.2019.11.07","volume":"12","author":"YF Gao","year":"2019","unstructured":"Gao YF, Liu RJ, Li YX, Huang C, Liu YY, Hu CX, et al. Comparison of anti-inflammatory effects of intense pulsed light with tobramycin\/dexamethasone plus warm compress on dry eye associated meibomian gland dysfunction. Int J Ophthalmol. 2019;12(11):1708\u201313.","journal-title":"Int J Ophthalmol"},{"issue":"5","key":"284_CR43","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/ICO.0000000000000807","volume":"35","author":"R Akiyama-Fukuda","year":"2016","unstructured":"Akiyama-Fukuda R, Usui T, Yoshida T, Yamagami S. Evaluation of tear meniscus dynamics using anterior segment swept-source optical coherence tomography after topical solution instillation for dry eye. Cornea. 2016;35(5):654\u20138.","journal-title":"Cornea"},{"key":"284_CR44","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2147\/OPTH.S318885","volume":"15","author":"A Marta","year":"2021","unstructured":"Marta A, Baptista PM, Marques J, Almeida D, Jos\u00e9 D, Sousa P, et al. Intense pulsed plus low-level light therapy in meibomian gland dysfunction. Clin Ophthalmol. 2021;15:2803\u201311.","journal-title":"Clin Ophthalmol"},{"key":"284_CR45","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.2147\/OPTH.S307020","volume":"15","author":"MA P\u00e9rez-Silguero","year":"2021","unstructured":"P\u00e9rez-Silguero MA, P\u00e9rez-Silguero D, Rivero-Santana A, Bernal-Blasco MI, Encinas-Pisa P. Combined intense pulsed light and low-level light therapy for the treatment of dry eye: a retrospective before-after study with one-year follow-up. Clin Ophthalmol. 2021;15:2133\u201340.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"284_CR46","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jtos.2020.09.001","volume":"18","author":"E Villani","year":"2020","unstructured":"Villani E, Marelli L, Dellavalle A, Serafino M, Nucci P. Latest evidences on meibomian gland dysfunction diagnosis and management. Ocul Surf. 2020;18(4):871\u201392.","journal-title":"Ocul Surf"}],"container-title":["Eye and Vision"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-022-00284-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40662-022-00284-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-022-00284-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:30:05Z","timestamp":1648780205000},"score":1,"resource":{"primary":{"URL":"https:\/\/eandv.biomedcentral.com\/articles\/10.1186\/s40662-022-00284-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["284"],"URL":"https:\/\/doi.org\/10.1186\/s40662-022-00284-4","relation":{},"ISSN":["2326-0254"],"issn-type":[{"value":"2326-0254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"assertion":[{"value":"12 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted at the Department of Ophthalmology of the Hospital Cl\u00ednico San Carlos in Madrid (Spain) following the tenets of the Declaration of Helsinki. All patients were informed about the nature of the study and provided written consent before being included in the trial. The study was approved by the Clinical Investigation Ethics Committee of the San Carlos Clinic Hospital in Madrid. (20\/588-E).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no proprietary or commercial interest in the medical devices that are involved in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}